Compare AAON & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAON | GRFS |
|---|---|---|
| Founded | 1988 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 5.8B |
| IPO Year | 1995 | N/A |
| Metric | AAON | GRFS |
|---|---|---|
| Price | $81.34 | $8.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $107.75 | $10.15 |
| AVG Volume (30 Days) | 731.6K | ★ 732.8K |
| Earning Date | 04-29-2026 | 07-28-2022 |
| Dividend Yield | 0.48% | ★ 1.73% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $1,442,076,000.00 | N/A |
| Revenue This Year | $21.49 | $5.33 |
| Revenue Next Year | $13.70 | $6.50 |
| P/E Ratio | $64.86 | ★ $18.67 |
| Revenue Growth | ★ 20.11 | N/A |
| 52 Week Low | $62.00 | $6.19 |
| 52 Week High | $116.04 | $11.14 |
| Indicator | AAON | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 42.28 | 51.24 |
| Support Level | $75.27 | $7.52 |
| Resistance Level | $87.20 | $9.11 |
| Average True Range (ATR) | 4.42 | 0.20 |
| MACD | 0.25 | 0.09 |
| Stochastic Oscillator | 38.83 | 93.26 |
AAON Inc is a manufacturer of air-conditioning and heating equipment. The products include rooftop units, chillers, packaged outdoor mechanical rooms, air-handling units, makeup air units, energy-recovery units, condensing units, geothermal heat pumps, and self-contained units and coils. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It generates the majority of its revenue from the AAON Oklahoma segment which derives maximum revenue, engineers, manufactures, and sells, semi-custom, and custom HVAC systems, designs and manufactures control solutions, and sells retail parts to customers through retail part stores and online.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.